Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Since the launch in 2008 by the National Osteoporosis Guideline Group (NOGG), of guidance for the diagnosis and management of osteoporosis in postmenopausal women and older men in the UK there have been significant advances in risk assessment and treatment. These have been incorporated into an updated version of the guideline, with an additional focus on the management of glucocorticoid-induced osteoporosis, the role of calcium and vitamin D therapy and the benefits and risks of long-term bisphosphonate therapy. The updated guideline is summarised below. The recommendations in the guideline are intended to aid management decisions but do not replace the need for clinical judgement in the care of individuals in clinical practice.

Original publication

DOI

10.1016/j.maturitas.2013.05.013

Type

Journal article

Journal

Maturitas

Publication Date

08/2013

Volume

75

Pages

392 - 396

Addresses

University of Cambridge School of Clinical Medicine, Cambridge, UK. jec1001@hermes.cam.ac.uk

Keywords

National Osteoporosis Guideline Group, Humans, Osteoporosis, Calcium, Dietary, Diphosphonates, Vitamin D, Glucocorticoids, Risk Assessment, Aged, Aged, 80 and over, Middle Aged, Female, Male, Bone Density Conservation Agents, Fractures, Bone, United Kingdom